Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Alginate oligosaccharide (G-block) fragment

EU orphan designation number: EU/3/07/475   
Active ingredient: Alginate oligosaccharide (G-block) fragment
Indication: Treatment of cystic fibrosis
Sponsor: AlgiPharma AS
Industriveien 33, N-1337 Sandvika, Norge

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
19/09/2007 Centralised Orphan - Designation EMEA/OD/104/06 (2007)4337 of 14/09/2007
04/02/2009 Other procedure